Oryzon Genomics Cash from Financing (Quarterly) Trends

Oryzon Genomics SA (ORYZF)

3.31 0.00 (0.00%) USD | OTCM | Sep 18, 16:00

Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ORYZF.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Cash from Financing (Quarterly) Chart

Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to . Start Trial.

Date	Value

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks

Start Trial

Pharma Mar SA	-0.0493M
Grifols SA	-337.83M
ACADIA Pharmaceuticals, Inc.	10.49M
Alkermes Plc	17.20M
Alnylam Pharmaceuticals, Inc.	36.24M